(Q83173428)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19136932%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

title

IGF2BP3 (IMP3) expression is a marker of unfavorable prognosis in ovarian carcinoma of clear cell subtype (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19136932%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19136932%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19136932%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

C Blake Gilks

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19136932%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Haodong Xu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19136932%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Patricia A Bourne

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19136932%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Betsy O Spaulding

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19136932%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Ie-Ming Shih

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19136932%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Tsui-Lien Mao

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19136932%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Carol A Ewanowich

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19136932%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Steve E Kalloger

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19136932%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Erika Mehl

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19136932%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Cheng-Han Lee

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19136932%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

David Huntsman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19136932%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

9 January 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19136932%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19136932%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19136932%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19136932%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

469-475

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19136932%20AND%20SRC:MED&resulttype=core&format=json

The RNA-binding protein IMP-3 is a translational activator of insulin-like growth factor II leader-3 mRNA during proliferation of human K562 leukemia cells

19 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.206

7 January 2021

CRD-BP/IMP1 expression characterizes cord blood CD34+ stem cells and affects c-myc and IGF-II expression in MCF-7 cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.206

7 January 2021

Spatial regulation of beta-actin translation by Src-dependent phosphorylation of ZBP1.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.206

7 January 2021

Expression of the highly conserved RNA binding protein KOC in embryogenesis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.206

7 January 2021

Expression of the RNA-binding protein IMP1 correlates with poor prognosis in ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.206

7 January 2021

Cloning of a gene highly overexpressed in cancer coding for a novel KH-domain containing protein

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.206

7 January 2021

Analysis of RNA-binding protein IMP3 to predict metastasis and prognosis of renal-cell carcinoma: a retrospective study

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.206

7 January 2021

External validation of IMP3 expression as an independent prognostic marker for metastatic progression and death for patients with clear cell renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.206

7 January 2021

Clinicopathologic analysis of early-stage sporadic ovarian carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.206

7 January 2021

Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.206

7 January 2021

Clear cell carcinoma of the ovary: a retrospective multicentre experience of 254 patients with complete surgical staging.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.206

7 January 2021

Grading ovarian serous carcinoma using a two-tier system

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.206

7 January 2021

Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.206

7 January 2021

Comparison of the usefulness between a new universal grading system for epithelial ovarian cancer and the FIGO grading system.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.206

7 January 2021

High-grade neuroendocrine carcinomas of the lung express K homology domain containing protein overexpressed in cancer but carcinoid tumors do not

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.206

7 January 2021

The oncofetal protein IMP3: a novel biomarker for endometrial serous carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.206

7 January 2021

IMP3 is a novel biomarker for adenocarcinoma in situ of the uterine cervix: an immunohistochemical study in comparison with p16(INK4a) expression

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.206

7 January 2021

Oncofetal protein IMP3: a novel molecular marker that predicts metastasis of papillary and chromophobe renal cell carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.206

7 January 2021

IMP3 predicts aggressive superficial urothelial carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.206

7 January 2021

Renal cell carcinoma: new developments in molecular biology and potential for targeted therapies

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.206

7 January 2021

Ovarian clear cell adenocarcinoma: a continuing enigma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.206

7 January 2021

RNA-binding IMPs promote cell adhesion and invadopodia formation

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.206

7 January 2021

DNA methylation changes in ovarian cancer: implications for early diagnosis, prognosis and treatment

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.206

7 January 2021

High-resolution single nucleotide polymorphism array analysis of epithelial ovarian cancer reveals numerous microdeletions and amplifications

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.206

7 January 2021

A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.206

7 January 2021